Evidence map›Paper›PMID 35111240›Full record

ReviewInterventional cardiology (London, England)2022

Futility in Transcatheter Aortic Valve Implantation: A Search for Clarity.

Kush P Patel, Thomas A Treibel, Paul R Scully, Michael Fertleman, Samuel Searle, Daniel Davis, James C Moon, Michael J Mullen

Abstract readReview
In one paragraph

Review in Interventional cardiology (London, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kush P PatelInstitute of Cardiovascular Sciences, University College London London, UK.
Thomas A TreibelInstitute of Cardiovascular Sciences, University College London London, UK.
Paul R ScullyInstitute of Cardiovascular Sciences, University College London London, UK.
Michael FertlemanCutrale Perioperative and Ageing Group, Department of Bioengineering, Imperial College London London, UK.
Samuel SearleMRC Unit for Lifelong Health and Ageing, University College London London, UK.
Daniel DavisMRC Unit for Lifelong Health and Ageing, University College London London, UK.
James C MoonInstitute of Cardiovascular Sciences, University College London London, UK.
Michael J MullenInstitute of Cardiovascular Sciences, University College London London, UK.

Funding

British Heart Foundation FS/19/35/34374Wellcome Trust 107467/Z/15/Z
6 · The paper itself

Abstract

Although transcatheter aortic valve implantation (TAVI) has revolutionised the landscape of treatment for aortic stenosis, there exists a cohort of patients where TAVI is deemed futile. Among the pivotal high-risk trials, one-third to half of patients either died or received no symptomatic benefit from the procedure at 1 year. Futility of TAVI results in the unnecessary exposure of risk for patients and inefficient resource utilisation for healthcare services. Several cardiac and extra-cardiac conditions and frailty increase the risk of mortality despite TAVI. Among the survivors, these comorbidities can inhibit improvements in symptoms and quality of life. However, certain conditions are reversible with TAVI (e.g. functional mitral regurgitation), attenuating the risk and improving outcomes. Quantification of disease severity, identification of reversible factors and a systematic evaluation of frailty can substantially improve risk stratification and outcomes. This review examines the contribution of pre-existing comorbidities towards futility in TAVI and suggests a systematic approach to guide patient evaluation.

Indexed as

aortic stenosisfrailtyfutilitymultimorbidityresource utilisationrisk stratificationTranscatheter aortic valve implantation

Identifiers

PMID35111240
PMCPMC8790725

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.